Andrey Susekov

Moscow, Russia

Cardiology Research Complex

Andrey V Susekov works as a Leading Research Fellow, Associate Professor and Head, Lipid Research Laboratory at Cardiology Research Complex, Moscow. Dr A Susekov graduated from Tomsk Medical Institute in 1986, West Siberia, Russia and rotated in Clinical Cardiology, All-union Cardiology Research Center (CRC) in 1986–1989. In 1989 Dr Susekov completed his Ph.D. thesis dedicated methodology o Lp(a)-apheresis in CHD patients. In 1993 he was awarded ESC Training Fellowship to study clinical lipidology in the Hammersmith Hospital, London, UK In 1994 he returned back to CRC, Moscow and continued his work in cardiology/li­pidology.

His doctoral thesis was dedicated optimization of lipid-lowering therapy in very high risk CHD patients. In 2002 Dr Andrey Susekov had training on Lipid Metabolism and lipoprotein kinetics in the Department of Medicine, Royal Perth Hospital, Western Australia. Over the past years Dr A Susekov was involved in local and international clinical trials with lipid lowering drugs.

He was among the first clinicians who introduced therapy with high doses of statins and modern combinations of lipid-lowering drugs in Russia. Dr A Susekov organized and performed several randomized lipid lowering trials (MSS, ESCAPE, ESCADRA, FARVATER) and took an active part in writing National Lipid Guidelines (2009, 2012).

Andrey Susekov participated in more than 30 international trials of novel lipid lowering drugs. He is member of International Atherosclerosis Advisory Boards and Expert Panels. Andrey V Susekov is an active lecturer in the field of dyslipideamia and atherosclerosis. Dr A Susekov run a popular Virtual Lipid Clinic in the Internet. Dr A Susekov is an experienced clinical lipidologist and Head of a large Lipid Clinic in Moscow.

He is author and co-author of more than 200 papers published in Russian and international journals, author of 2 books. Dr Andrey Susekov is one of the most experienced lipidologist in Russia , he is member of Expert Committee of Russian Atherosclerosis Society, member of EAS, IAS, NLA, ACC and AHA.

Sessions by Andrey Susekov

Lowering LDL-С or non HDL-C with statins: Which comes first?

Monday (25 May) 15:05 - 15:25

  • Type:
    Russian Symposium I
  • Theme:
    Statin therapy at the crossroad of the decade: what we know and what we would like to know.
  • Track:

Stay up to date, subscribe to the newsletter

Progression and prevention of atherosclerosis and a translation to relevance.